Publications by authors named "Daniela Belotti"

Claim this Profile
O
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability.
Ilaria Pisani, Giusi Melita, Patricia Borges de Souza, Stefania Galimberti, Angela Maria Savino, Daniela Belotti

J Transl Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation.
Federico Lussana, Chiara F Magnani, Stefania Galimberti, Giuseppe Gritti, Giuseppe Gaipa, Daniela Belotti

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MesenchymAl stromal cells for Traumatic bRain Injury (MATRIx): a study protocol for a multicenter, double-blind, randomised, placebo-controlled phase II trial.
Elisa R Zanier, Francesca Pischiutta, Eliana Rulli, Alessia Vargiolu, Francesca Elli, Daniela Belotti

Intensive Care Med Exp· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study.
Angela Genchi, Elena Brambilla, Francesca Sangalli, Marta Radaelli, Marco Bacigaluppi, Daniela Belotti

Nat Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies.
Chiara Capelli, Simona Frigerio, Daniela Lisini, Sara Nava, Giuseppe Gaipa, Daniela Belotti

Cytotherapy· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities.
Chiara F Magnani, Giuseppe Gaipa, Federico Lussana, Daniela Belotti, Giuseppe Gritti

J Clin Invest· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133 cells in ischemic refractory cardiomyopathy trial (RECARDIO).
Beatrice Bassetti, Corrado Carbucicchio, Valentina Catto, Elisa Gambini, Erica Rurali, Daniela Belotti

Stem Cell Res Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation.
Martino Introna, Federico Lussana, Alessandra Algarotti, Elisa Gotti, Rut Valgardsdottir, Daniela Belotti

Biol Blood Marrow Transplant· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full GMP-compliant validation of bone marrow-derived human CD133(+) cells as advanced therapy medicinal product for refractory ischemic cardiomyopathy.
Daniela Belotti, Giuseppe Gaipa, Beatrice Bassetti, Benedetta Cabiati, Gabriella Spaltro

Biomed Res Int· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients.
Martino Introna, Giovanna Lucchini, Erica Dander, Stefania Galimberti, Attilio Rovelli, Daniela Belotti

Biol Blood Marrow Transplant· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population.
Giovanna Lucchini, Martino Introna, Erica Dander, Attilio Rovelli, Adriana Balduzzi, Daniela Belotti

Biol Blood Marrow Transplant· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy.
Giuseppe Gaipa, Manuela Tilenni, Stefania Straino, Ilaria Burba, Germana Zaccagnini, Daniela Belotti

J Cell Mol Med· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The washouts of discarded bone marrow collection bags and filters are a very abundant source of hMSCs.
Chiara Capelli, Agnese Salvade, Olga Pedrini, Valentina Barbui, Elisa Gotti, Daniela Belotti

Cytotherapy· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies.
Elena Bresin, Sara Gastoldi, Erica Daina, Daniela Belotti, Enrico Pogliani

Thromb Haemost· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD34+ stem cell recovery after positive selection of "overloaded" immunomagnetic columns.
Paolo Perseghin, Giuseppe Gaipa, Maria Dassi, Daniela Belotti, Enrico Maria Pogliani

Stem Cells Dev· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frozen-and-thawed allogeneic platelet gels for treating postoperative chronic wounds.
Paolo Perseghin, Gianalfredo Sciorelli, Daniela Belotti, Tiziana Speranza, Enrico M Pogliani

Transfusion· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report.
Miriam Galbusera, Elena Bresin, Marina Noris, Sara Gastoldi, Daniela Belotti

Blood· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement activation: the missing link between ADAMTS-13 deficiency and microvascular thrombosis of thrombotic microangiopathies.
Maria Piedad Ruiz-Torres, Federica Casiraghi, Miriam Galbusera, Daniela Macconi, Sara Gastoldi, Daniela Belotti

Thromb Haemost· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Platelet activation during plasma-reduced multicomponent PLT collection: a comparison between COBE Trima and Spectra LRS turbo cell separators.
Paolo Perseghin, Luca Mascaretti, Tiziana Speranza, Daniela Belotti, Valentina Baldini

Transfusion· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Congenital absence of the inferior vena cava and genetic coagulation abnormalities: a rare associated risk factor for recurrent idiopathic deep vein thrombosis.
Matteo Parma, Daniela Belotti, Sara Marinoni, Enrico Maria Pogliani

Clin Appl Thromb Hemost· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis